[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100540395":3},{"organization":4,"outcomesModule":7,"designInfo":25,"detailedDescription":24,"studyPopulation":28,"armGroups":29,"interventions":24,"overallOfficials":24,"centralContacts":39,"locations":45,"responsibleParty":58,"collaborators":62,"id":66,"slug":24,"hasResults":67,"nctId":68,"briefTitle":69,"officialTitle":70,"acronym":24,"eligibilityCriteria":71,"healthyVolunteers":72,"sex":73,"minAge":74,"maxAge":75,"enrollmentInfo":76,"targetDuration":24,"studyType":79,"phases":24,"briefSummary":80,"conditions":81,"keywords":83,"overallStatus":88,"whyStopped":24,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Josip Juraj Strossmayer University of Osijek","OTHER",{"primaryOutcomes":8,"secondaryOutcomes":19,"otherOutcomes":24},[9,13,16],{"measure":10,"description":11,"timeFrame":12},"Systemic microvascular function","Skin microvascular reactivity assessed by Laser Doppler flowmetry (post-occlusive reactive hyperemia, iontophoresis of acetylcholine and sodium nitroprusside) - measured in perfusion units (PU)","Day 1",{"measure":14,"description":15,"timeFrame":12},"Serum level of antixidant enzymesprotein concentration of SOD, CAT and glutathione-peroxidase","Serum protein concentration of superoxide disimutase (SOD), catalase (CAT) and glutathione-peroxidase (GPx).",{"measure":17,"description":18,"timeFrame":12},"Detecton of miRNA of interest","The database for miRNA will be searched, and the miRNA of interest will be selected, determined and detected.",[20],{"measure":21,"description":22,"timeFrame":23},"Body fluid compartments","Total body water (L), extracellular water (L), intracellular water (L) and plasma fluid volume (L) will be assessed using non-invasive bioimpedance analysis (BIA).","at one time point",null,{"allocation":24,"interventionModel":24,"interventionModelDescription":24,"primaryPurpose":24,"observationalModel":26,"timePerspective":27,"maskingInfo":24},"CASE_CROSSOVER","CROSS_SECTIONAL","Patients with CKD and healthy controls, i.e. patients with hypertension without kidney damage (eGFR CKD-EPI \\> 90 mL\u002Fmin\u002F1.73 m2). Subjects and controls will be age- and gender-matched. Inclusion criteria for patients with CKD: the study will include patients having chronic kidney disease of the 3rd - 5th degree (eGFR CKD-EPI\\\u003C 60 mL\u002Fmin\u002F1.73 m2).",[30,33,36],{"label":31,"type":24,"description":32,"interventionNames":24},"Chronic kidney disease group","Patients with stage 3-5 CKD (eGFR CKD-EPI \\\u003C60 mL\u002Fmin\u002F1.73 m2)",{"label":34,"type":24,"description":35,"interventionNames":24},"Healthy controls","Healthy normotensive patients (eGFR CKD-EPI \\>90 mL\u002Fmin\u002F1.73 m2, BP \\\u003C140\u002F90 mmHg)",{"label":37,"type":24,"description":38,"interventionNames":24},"Hypertensive Group","Hypertensive patients without CKD (eGFR CKD-EPI \\>90 mL\u002Fmin\u002F1.73 m2, BP \\>140\u002F90 mmHg)",[40],{"name":41,"role":42,"phone":43,"phoneExt":24,"email":44},"Ines Drenjančević, MD, PhD","CONTACT","+38531512800","ines.drenjancevic@mefos.hr",[46],{"facility":47,"status":24,"city":48,"state":24,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":24},"Faculty of Medicine Osijek","Osijek","31000","Croatia","HR",{"type":53,"coordinates":54},"Point",[55,56],18.6942,45.55066,{"lat":56,"lon":55},{"type":59,"investigatorFullName":60,"investigatorTitle":61,"investigatorAffiliation":5,"oldNameTitle":24,"oldOrganization":24},"PRINCIPAL_INVESTIGATOR","Ines Drenjancevic","Vice Dean for Science Faculty of Medicine Osijek",[63],{"name":64,"class":65},"University Hospital Center Osijek","UNKNOWN","100540395",false,"NCT06316284","miRNA in Chronic Kidney Diseases","The Role of miRNAs in the Regulation of Oxidative Stress and Microvascular Reactivity in Chronic Kidney Disease","Inclusion Criteria:\n\n* healthy normotensive adults (eGFR CKD-EPI \\>90 mL\u002Fmin\u002F1.73 m2, BP \\\u003C140\u002F90 mmHg)\n* hypertensive adults (eGFR CKD-EPI \\>90 mL\u002Fmin\u002F1.73 m2, BP \\>140\u002F90 mmHg)\n* patients with chronic kidney disease stage 3-5 (eGFR CKD-EPI\\\u003C 60 mL\u002Fmin\u002F1.73 m2)\n\nExclusion Criteria:\n\n* cardiovascular diseases, but hypertension\n* diabetes\n* cerebrovascular diseases\n* peripheral artery disease",true,"ALL","18 Years","69 Years",{"count":77,"type":78},90,"ESTIMATED","OBSERVATIONAL","Oxidative stress and endoplasmic reticulum (ER) stress play a key role in tubular damage in both acute kidney injury and chronic kidney disease (CKD). Oxidative stress in the kidneys promotes renal vascular remodeling and increases preglomerular resistance. These are key elements in hypertension, acute and chronic kidney injury, as well as diabetic nephropathy. Chronic renal hypoxia is highlighted as the final common pathway to end-stage renal disease (ESRD). MicroRNA molecules (miRNA) also play an important role in these processes. MicroRNAs (miRNAs) are regulators of gene expression and play a role in the progression of renal ischemia-reperfusion injury. Although the pathophysiological contribution of microRNAs (miRNAs) to kidney damage has also been highlighted, the effect of miRNAs on kidney damage under conditions of oxidative and ER stress remains understudied.",[82],"Chronic Kidney Diseases",[84,85,86,87],"chronic kidney diseases","miRNA","oxidative stress","hypertension","NOT_YET_RECRUITING","2024-03-11",{"date":91,"type":92},"2024-03-18","ACTUAL",{"date":94,"type":78},"2024-04-01",{"date":96,"type":78},"2026-12-31",{"name":5,"class":6},1]